Parent Terms |
Term With Siblings |
Child Terms |
|
(-)-epigallocatechin 3-gallate +
(-)-N(6)-(2-phenylisopropyl)adenosine
(25R)-cholest-5-ene-3beta,26-diol +
(3R,4S,1'R)-3-(1'-hydroxyethyl)-4-methyldihydrofuran-2(3H)-one
(R,R)-5,11-diethyl-5,6,11,12-tetrahydro-2,8-chrysenediol
1-hydroxy-5-phenyl-3-pentanone
1-isothiocyanato-6-(methylsulfanyl)hexane
3-hydroxymethyl-4-methyl-furan-2(5H)-one
5,5-dimethyl-1-pyrroline N-oxide
6alpha-methylprednisolone +
7beta-hydroxyepiandrosterone
Ac-Tyr-Val-Ala-Asp-chloromethylketone
ajugamarin A1 chlorohydrin
ajugamarin A2 chlorohydrin
arachidonyl-2'-chloroethylamide
aspirin-triggered protectin D1
bis-(4-hydroxybenzyl)sulfide
bupivacaine hydrochloride (anhydrous) +
bupivacaine hydrochloride hydrate
Delta(9)-tetrahydrocannabinolic acid
dihydroergotamine tartrate
fasudil hydrochloride hydrate
glycoursodeoxycholic acid
levobupivacaine hydrochloride (anhydrous) +
levobupivacaine hydrochloride hydrate +
methanol extract of Sorbus alnifolia
methyl 3,4-dihydroxybenzoate
N,N'-bis(diphenylmethyl)ethane-1,2-diamine
N-[2-(4-phenoxybenzyl)benzimidazol-5-yl]methanesulfonamide
N-\{2-[(4-benzylpiperidin-1-yl)methyl]benzimidazol-5-yl\}methanesulfonamide
N-palmitoyl-S-[2,3-bis(palmitoyloxy)propyl]-Cys-Ser-Lys-Lys-Lys-Lys
N-tert-butyl(3,5,6-trimethylpyrazin-2-yl)methanimine N-oxide
neostigmine methyl sulfate
nicotinyl alcohol tartrate
NNC 55-0396 (free base) +
NNC 55-0396 dihydrochloride
p-Glu-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe
pyrrolidine dithiocarbamate
rivastigmine tartrate A tartrate salt obtained by reaction of rivastigmine with one equivalent of (R,R)-tartaric acid. A reversible cholinesterase inhibitor.
S-methyl-L-thiocitrulline
tauroursodeoxycholic acid
tropisetron hydrochloride
|
|
|
Synonyms |
Exact Synonyms: |
3-[(1S)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate (2R,3R)-2,3-dihydroxybutanedioate
|
Related Synonyms: |
(1S)-1-(3-{[ethyl(methyl)carbamoyl]oxy}phenyl)-N,N-dimethylethanaminium (2R,3R)-3-carboxy-2,3-dihydroxypropanoate
;
Exelon
;
Formula=C18H28N2O8
;
InChI=1S/C14H22N2O2.C4H6O6/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4;5-1(3(7)8)2(6)4(9)10/h7-11H,6H2,1-5H3;1-2,5-6H,(H,7,8)(H,9,10)/t11-;1-,2-/m01/s1
;
InChIKey=GWHQHAUAXRMMOT-MBANBULQSA-N
;
SDZ-ENA 713
;
SMILES=O[C@H]([C@@H](O)C(O)=O)C(O)=O.CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C
;
rivastigmine hydrogen tartrate
|
Xrefs: |
CAS:129101-54-8
;
DrugBank:DB00989
;
KEGG:D02558
;
PMID:15119476
;
PMID:17122027
;
PMID:17612707
;
PMID:21880452
;
Patent:EP1980552
;
Patent:EP2233465
;
Patent:US2008255383 |
|